Interestingly, miR-101-3p engages with EZH2, impeding RB tumor cell formation [67], while the inhibition of EZH2 through specific inhibitors displays therapeutic potential against RB by inhibiting proliferation and metastasis [68]. The gene discussed is EZH2; the disease is neoplasm.